Trials / Conditions / APOL1-mediated Kidney Disease
APOL1-mediated Kidney Disease
3 registered clinical trials studyying APOL1-mediated Kidney Disease — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | APOL1 Genotyping CTA Clinical Performance Study NCT06839833 | Almac Diagnostic Services LLC | N/A |
| Recruiting | Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Di NCT06824987 | AstraZeneca | Phase 2 |
| Completed | A Phase 1 Dose Escalation Study to Evaluate Safety and Pharmacokinetics (PK) of VX-840 in Healthy Participants NCT05324410 | Vertex Pharmaceuticals Incorporated | Phase 1 |